Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer Mechanisms and Therapy, Cancer, Hypoxia, and Metabolism, and Ferroptosis and cancer prognosis.
AAMP is a binding partner of costimulatory human B7-H3
Radioresistance and Transcriptional Reprograming of Invasive Glioblastoma Cells
LAPTM5–CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance
Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche
cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma
P11.07 LAPTM5 functions as a tumor suppressor via CD40 - NFêB pathway inhibition and represents a potential biomarker for temozolomide sensitivity in CD40 proficient glioblastoma
Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib
Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma
Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas
P08.19 Resistance towards the MDM2 inhibitor idasanutlin is mediated via the NFkB pathway and IGFBP1 upregulation in glioblastoma
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy
Brain tumour cells interconnect to a functional and resistant network
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
Herg K+ Channel-Dependent Apoptosis and Cell Cycle Arrest in Human Glioblastoma Cells
Microenvironmental Clues for Glioma Immunotherapy
BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1
Glioma Invasion Confers Radioresistance